Welcome to LookChem.com Sign In|Join Free

CAS

  • or

917562-21-1

Post Buying Request

917562-21-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

917562-21-1 Usage

Class of compound

Nitrobenzene

Physical state at room temperature

Pale yellow solid

Common uses

a. Organic synthesis
b. Reagent in chemical reactions
c. Intermediate in the manufacture of pharmaceuticals, agrochemicals, and dyes
d. Precursor for the synthesis of other organic compounds

Hazardous nature

Yes, considered a hazardous chemical

Safety precautions

Proper safety measures should be taken when handling and using the compound

Check Digit Verification of cas no

The CAS Registry Mumber 917562-21-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,7,5,6 and 2 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 917562-21:
(8*9)+(7*1)+(6*7)+(5*5)+(4*6)+(3*2)+(2*2)+(1*1)=181
181 % 10 = 1
So 917562-21-1 is a valid CAS Registry Number.

917562-21-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-bromo-2-chloro-4-methoxy-5-nitrobenzene

1.2 Other means of identification

Product number -
Other names 4-Bromo-3-chloro-6-nitroanisole

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:917562-21-1 SDS

917562-21-1Downstream Products

917562-21-1Relevant articles and documents

COMBINATION THERAPIES FOR TREATMENT OF CANCER

-

Paragraph 322; 323, (2016/04/09)

Combination therapies for treatment of cancers associated with mutations in the KRAS gene are provided. Compositions comprising therapeutic agents for treatment of cancers associated with mutations in the KRAS gene are also provided.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 917562-21-1